FNYS
ANAC

First New York Securities’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

First New York Securities’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-35
Closed -$2.02K – 643
2015
Q1 		$2.02K Buy
+35
New +$1.49K ﹤0.01% 345

Other funds holding ANAC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM

First New York Securities's ANAC Position: Q2 2015 in Review

First New York Securities sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2015, closing a stake of 35 shares — an estimated $2.02K sold.

First New York Securities first reported a position in ANAC in Q1 2015 and held it in 1 quarter. The position peaked at $2.02K in Q1 2015. 177 funds tracked by Wall St. Rank hold ANAC as of Q2 2015.

  • First New York Securities reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2015 after selling out during the quarter.
  • First New York Securities sold 35 ANACOR PHARMACEUTICALS INC COM shares in Q2 2015, an estimated $2.02K.
  • First New York Securities first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2015 and held it in 1 quarter.
  • First New York Securities's ANACOR PHARMACEUTICALS INC COM position peaked at $2.02K in Q1 2015.
  • 177 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2015.

Based on First New York Securities's 13F filing for Q2 2015, filed 30 Jul 2015.